Cholinergic stimulation with pyridostigmine blunts the cardiac responses to mental stress

Clinical Autonomic Research

Volumn 9, Issue 1, 1999, Pages 11-16

  Nóbrega, Antonio C L ^a   Carvalho, Ana C G ^a   Santos, Kelb B ^a   Soares, Pedro Paulo S ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Blood pressure; Cholinesterase; Heart rate; Humans; Parasympathetic system; Rate pressure product

Indexed keywords

CHOLINESTERASE INHIBITOR; PLACEBO; PYRIDOSTIGMINE;

ADULT; ARITHMETIC; ARTICLE; CHOLINERGIC STIMULATION; CHRONOTROPISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN EXPERIMENT; HYPERSALIVATION; MALE; MENTAL STRESS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RR INTERVAL; SYSTOLIC BLOOD PRESSURE; VOLUNTEER;

EID: 0032945997     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02280691     Document Type: Article

References (38)

1. Lown B, Verrier RL, Rabinowitz SH. Neural and psychologic mechanisms and the problem of sudden cardiac death. Am J Cardiol 1977; 39:890-972.
2. Nyberg G, Graham RM, Stokes GS. The effect of mental arithmetic in normotensive and hypertensive subjects, and its modification by beta-adrenergic receptor blockade. Br J Clin Pharmacol 1977; 4:469-474.
3. Kasprowicz AL, Manuck SB, Malkoff SB, Krantz DS. Individual differences in behaviorally evoked cardiovascular response: temporal stability and hemodynamic patterning. Psychophysiology 1990; 27:605-619.
4. Hoshikawa Y, Yamamoto Y. Effects of Stroop color-word conflict test on the autonomic nervous system response. Am J Physiol 1997; 272 (Heart Circ Physiol, 41): H1113-H1121.
5. Specchia G, De Servi S, Falcone C, Gavazzi A, Angoli I, Bramucci E, Ardissino D, Mussini A. Mental arithmetic stress testing in patients with coronary artery disease. Am Heart J 1984; 108:56-63.
6. Zotti AM, Bettinardi O, Soffiantino F, Tavazzi L, Steptoe A. Psychophysiological stress testing in postinfarction patients - psychological correlates of cardiovascular arousal and abnormal cardiac responses. Circulation 1991; 83 (suppl II):II-25-II-35.
7. Legault SE, Freeman MR, Langer A, Armstrong PW. Pathophysiology and time course of silent myocardial ischaemia during mental stress: clinical, anatomical, and physiological correlates. Br Heart J 1995; 73:242-249.
8. Harvey WP, Levine AS. Paroxysmal ventricular tachycardia due to emotion. Possible mechanism of death due to fright. JAMA 1952; 150:479-480.
9. Lown B, De Silva RA, Lenson R. Roles of psychologic stress and autonomic nervous system changes in provocation of ventricular premature complexes. Am J Cardiol 1978; 41:979-985.
10. Reich P, Da Silva DA, Lown B, Murawski J. Acute psychological disturbance preceeding life-threatening ventricular arrhythmias. JAMA 1981; 246:233-235.
11. Kent KM, Smith ER, Redwood DR, et al. Electrical stability of acutely ischemic myocardium: influences of heart rate and vagal stimulation. Circulation 1973; 47:291-298.
12. De Silva RA, Verrier RL, Lown BL. The effects of psychological stress and vagal stimulation with morphine on vulnerability to ventricular fibrillation (VF) in the conscious dog. Am Heart J 1978; 95:197-203.
13. Casadei B, Pipilis A, Sessa F, Conway J, Sleight P. Low doses of scopolamine increase cardiac vagal tone in the acute phase of myocardial infarction. Circulation 1993; 88:353-357.
14. De Ferrari GM, Mantica M, Vanoli E., et al. Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. J Am Coll Cardiol 1993; 22:1327-1234.
15. Pedretti R, Colombo E, Simona SB et al. Influence of transdermal scopolamine on cardiac sympathovagal interaction after acute myocardial infarction. Am J Cardiol 1993; 72:384-392.
16. Vybiral T, Glaeser DH, Morris G, Kenneth RH, Yang K, Francis M, Craig MP. Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction. J Am Coll Cardiol 1993; 22:1320-1326.
17. Hull SS, Vanoli E, Adamson PB, De Ferrari GM, Foreman RD, Schwartz PJ. Do increases in markers of vagal activity imply protection from sudden death? Circulation 1995; 91:2516-2519.
18. th ed. New York: McGraw-Hill; 1996: 161-176.
19. Grabe-Guimarães A, Alves LM, Sales MAM, Tibiriçá E, Nóbrega ACL. Pyridostigmine blunts the centrally-evoked increases in myocardial oxygen demand in anesthetized rats. JACC 1998; 31 suppl C:445.
20. Izraeli S, Alcalay M, Benjamini Y, Wallach-Kapon R, Tochner Z, Akselrod S. Modulation of the dose-dependent effects of atropine by low-dose pyridostigmine: quantification by spectral analysis of heart rate fluctuations in healthy human beings. Pharmacol Biochem Behav 1991; 39:613-617.
21. Nóbrega ACL, Carvalho ACG, Bastos BG. Resting and reflex heart rate responses during cholinergic stimulation with pyridostigmine in humans. Brazilian J Med Biol Res 1996; 29:1461-1465.
22. Reis AF, Moraes RS, Bastos BG, Ferlin E, Ribeiro JP, Nóbrega ACL. Heart rate variability during cholinergic stimulation with pyridostigmine in healthy subjects. J Am Coll Cardiol 1998; 31(suppl. C):407C.
23. Pontes PV, Bastos BG, Mesquita ET, Nóbrega ACL. Cholinergic stimulation with pyridostigmine: echocardiographic analysis in healthy subjects. J Am Coll Cardiol 1998; 31(suppl. C):433C.
24. Stephenson LA and Kolka MA. Acetylcholinesterase inhibitor, pyridostigmine bromide, reduces skin blood flow in humans. Am J Physiol 1990; 258:R951-R957.
25. Odemuyiwa O, Malik M, Farrell T, et al. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol 1991; 68:434-438.
26. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ (for the ATRAMI Investigators). Baroreflex sensitivity and heartrate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351:478-484.
27. De Ferrari GM, Vanoli E, Schwartz PJ. Vagal activity and ventricular fibrillation. In: Levy MN, Schwartz PJ, eds. Vagal Control of the Heart: Experimental Basis and Clinical Implications. Armonk: Futura, 1994:613-636.
28. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992; 85 (Suppl I):I-77-I-99.
29. Levy MN. Sympathetic-parasympathetic interactions in the heart. Circ Res 1971; 29:437-445.
30. Verrier RL, Dickerson LW. Central nervous system and behavioral factors in vagal control of arrhythmogenesis. In: Levy MN, Schwartz PJ, eds. Vagal Control of the Heart: Experimental Basis and Clinical Implications. Armonk: Futura; 1994:557-577.
31. Grossman P, Watkins LL, Wilhelm FH, Manolakis D, Lown B. Cardiac vagal control and dynamic responses to psychological stress among patients with coronary artery disease. Am J Cardiol 1996; 78:1424-1427.
32. Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol 1971; 27:416-432.
33. Gobl FL, Nordstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate pressure product as an index of myocardial oxygen consumption during exercise in patients of angina pectoris. Circulation 1978; 58:549-556.
34. Levy MN and Zieske H. Comparison of the cardiac effect of vagus nerve stimulations and of acetylcholine infusions. Am J Physiol 1969; 216:890-897.
35. Löffelholz K, Pappano AJ. The parasympathetic neuroeffector junction of the heart. Pharmacol Rev 1985; 37:1-24
36. Jern S, Pilhall M, Jern C. Effect of cholinergic blockade on heart rate, blood pressure and plasma catecholamine responses to mental stress in normal subjects. Clin Auton Res 1991; 1:225-231.
37. Araújo CGS, Castro CLB, Nóbrega ACL. Heart rate responses to deep breathing and 4-seconds of exercise before and after pharmacological blockade with atropine and propranolol. Clin Auton Res 1992; 2:35-40.
38. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Circulation 1990; 81:482-490.